Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors

INTRODUCTION: (177)Lu-DOTATATE, a radionuclide therapy that binds somatostatin type-2A receptors (SST2A), has demonstrated efficacy in neuroendocrine tumors and evidence of central nervous system (CNS) penetration, supporting potential expansion within pediatric neuro-oncology. Understanding the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazow, Margot A., Fuller, Christine, Trout, Andrew T., Stanek, Joseph R., Reuss, Jaime, Turpin, Brian K., Szabo, Sara, Salloum, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713413/
https://www.ncbi.nlm.nih.gov/pubmed/36465400
http://dx.doi.org/10.3389/fonc.2022.996489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713413/
https://www.ncbi.nlm.nih.gov/pubmed/36465400
http://dx.doi.org/10.3389/fonc.2022.996489

Ejemplares similares